SCHEMBL22144945

SCHEMBL22144945

N=CC(N)Cc1cscn1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.39
▸ DPP8 Q6V1X1 2/20 0.39
▸ DPP9 Q86TI2 2/20 0.39
▸ SLC6A3 Q01959 9/20 0.34
▸ CAPN1 P07384 1/20 0.32
▸ OPRD1 P41143 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ GPR142 Q7Z601 1/20 0.30
▸ SLC6A2 P23975 2/20 0.30
▸ SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1696695 0.81 DPP4 (0.39) DPP4DPP8DPP9SLC6A3CAPN1
SCHEMBL2639846 0.81 DPP4 (0.39) DPP4DPP8DPP9SLC6A3CAPN1
SCHEMBL21299170 0.81 DPP4 (0.39) DPP4DPP8DPP9SLC6A3CAPN1
SCHEMBL16889011 0.75 — —
SCHEMBL20279044 0.72 DPP4 (0.39) DPP4DPP8DPP9SLC6A3CAPN1
SCHEMBL13624897 0.72 DPP4 (0.36) DPP4DPP8DPP9SLC6A3OPRD1
SCHEMBL7964213 0.72 DPP4 (0.39) DPP4DPP8DPP9SLC6A3CAPN1
SCHEMBL19143537 0.72 DPP4 (0.39) DPP4DPP8DPP9SLC6A3CAPN1
SCHEMBL7964218 0.72 DPP4 (0.39) DPP4DPP8DPP9SLC6A3CAPN1
SCHEMBL19214802 0.72 DPP4 (0.36) DPP4DPP8DPP9SLC6A3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021102052-A1 DIRECTED CONJUGATION TECHNOLOGIES KLEO PHARMACEUTICALS, INC. (US) 2021-05-27 — — WO disclosed
WO-2020132588-A1 COMBINATION THERAPY OF ARMS AND NATURAL KILLER CELLS KLEO PHARMACEUTICALS, INC. (US) 2020-06-25 — — WO disclosed
Send feedback